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Abstract 
In this review, we present and discuss a selected panel of antibody-defined markers expressed uring different 
stages of mouse macrophage development. We distinguish four categories of markers, which are characteristic of: (1) 
macrophage precursors and immature macrophages (ER-MP12, ER-MP20, ER-MP54, ER-MP58); (2) mature 
macrophages in general (F4/80, BM8, Mac-l, Mac-2, ER-BMDM1); (3) macrophage subsets (ER-HR3, ER-MP23, 
ER-TR9, Forssman antigen, MOMA-1, MOMA-2, Monts-4, SER-4), and (4) IFN-3,-stimulated macrophages (H-2Ia, 
LFA-1, ICAM-1, 158.2, MBR-2, TM-2, TM-4, and TM-5). It should be noted that many of the markers in this last 
category are inducible by other stimuli as well. The rigid classification of markers into four separate groups should 
be regarded as a digitalization of a continuum, thus inevitably implicating a simplification of the complex phenotypic 
changes that occur during mononuclear phagocyte development. Nevertheless, the current selection of antibodies 
against markers for different developmental stages of macrophages constitutes an important tool for characterization 
of mouse macrophages which participate in various biological processes. 
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1. Introduction 
The cell surface of the mouse macrophage has 
been mapped extensively since the introduction 
of hybridoma technology in the late seventies. An 
array of monoclonal antibodies elicited against 
different macrophage populations has been pro- 
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10-436 7601. 
duced and characterized (see Leenen and Camp- 
bell, 1993 for an overview). Yet, defining discrete, 
functional stages in mouse macrophage develop- 
ment using antibodies against discriminating de- 
terminants appeared to be much more compli- 
cated than describing functionally distinct lym- 
phocyte subtypes. 
The limited insight into the link between phe- 
notype and function of different macrophage 
populations may be ascribed primarily to the 
complexity of the mononuclear phagocyte system 
(see elsewhere in this volume and recent reviews 
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by us and others (Leenen and Campbell, 1993; 
Rutherford et al., 1993). Different macrophages 
are involved in a wide variety of processes, such 
as (1) clearance of potentially harmful substances, 
(2) killing of microorganisms and tumor cells, (3) 
regulation of and participation in inflammatory 
and immune responses, and (4) regulation of 
hemo-and lymphopoiesis. This functional diver- 
sity is clearly reflected in the phenotypic diversity 
of the various mononuclear phagocyte popula- 
tions, although it is often difficult to interpret 
observed phenotypic differences. 
In this review, we will discuss a selected panel 
of markers, detected by monoclonal antibodies, 
useful for the phenotypic characterization of 
mouse macrophages. Emphasis will be on the 
interpretation of phenotypic haracteristics - and 
on the limitations thereof - in terms of 
macrophage developmental stages and functional 
capabilities. To that end, we will first attempt o 
define the different processes in macrophage de- 
velopment, since many slightly different defini- 
tions are being used in the field. 
We regard the phenotypic and functional 
changes that macrophages undergo during devel- 
opment as being caused by either maturation, 
differentiation, or activation of the cells (sche- 
matically depicted in Fig. 1). Maturation is the 
process by which cells acquire features typical of 
cells in later stages of development, and lose 
aspects of earlier stages. Differentiation, in our 
view, is a specific type of maturational process by 
which diversity is generated. Both maturation and 
differentiation are, in principle, irreversible. In 
contrast, activation of macrophages is a re- 
versible process by which cells are stimulated to 
express particular functions or by which the ac- 
complishment of certain existing functions is en- 
hanced. These processes may occur concurrently, 
that is, a cell might both mature and become 
activated as a response to a specific stimulus. 
In accordance with the different developmen- 
tal processes, macrophage markers may be classi- 
fied as (1) maturation markers, which are either 
positively or negatively correlated with the cell's 
maturation stage, (2) differentiation or subset 
markers, which are expressed differentially by 
cells of similar maturation stages, and (3) activa- 
© 
Fig. 1. Schematic representation f different facets of macrophage d velopment. M = maturation; D = differentiation; A = 
activation; de-A = de-activation. 
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tion markers, whose expression can be induced or 
enhanced by particular external stimuli and is 
indicative of certain functional capabilities. In- 
evitably, the assignment of a particular marker to 
one of these categories depends ignificantly on 
the experimental models used to study matura- 
tion, differentiation a d activation. 
In our previous work, we have adopted and 
developed three different models for the identifi- 
cation of macrophage maturation markers, recog- 
nized by newly prepared and existing monoclonal 
antibodies. The first model consists of a panel of 
macrophage cell lines, which can be aligned in 
order of increasing maturity and represent stages 
ranging from CFU-GM to relatively mature exu- 
date macrophages (Leenen et al., 1986). M-CSF- 
stimulated bone marrow (BM) cell cultures abro- 
gated at different ime points provides a second 
maturation model (cf. Van der Meer et al., 1983, 
Walker et al., 1985). Thirdly, multiple macrophage 
precursor cell lines can be stimulated to develop 
into more mature stages by external stimuli, such 
as mouse post-endotoxin serum (Leenen et al., 
1990a). 
Models for the identification of macrophage 
differentiation r subset markers are not as clearly 
defined as the maturation models mentioned 
above. In the latter, homogeneous populations of 
mature cells are generated from precursors, and 
diversification, which is by definition the hall- 
mark of differentiation, is rarely observed. Yet, 
different macrophage subsets can be easily dis- 
cerned in situ by immunohistochemical analysis 
of complex organs uch as the spleen (Van Rooij- 
en et al., 1989). Here, phenotypically distinct 
macrophage subsets are found in different mi- 
croanatomical locations. The developmental rela- 
tionship between these subsets is unclear, but the 
cells do not show conclusive maturational differ- 
ences that might explain their phenotypic hetero- 
geneity. However, at some point in their develop- 
ment the distinct macrophage subsets share a 
common progenitor and thus represent the end- 
stages of a differentiation process. Therefore, to 
identify different subset markers we use immuno- 
histochemistry of macrophages in lymphoid and 
non-lymphoid organs as the main technique. 
Macrophage activation markers are, by defini- 
tion, induced by specific external stimuli and the 
expression of these markers decreases again when 
the stimulus is removed. As a screening model, 
macrophage c ll lines or primary BM cultures are 
stimulated with IFN-y, which is known to medi- 
ate several functional changes in a broad spec- 
trum of macrophages. For instance, IFN-y- 
stimulated macrophages show increased ability to 
present antigen to CD4 + T cells, as a conse- 
quence of increased MHC class II expression, 
and are primed for further stimulation to become 
tumoricidal (Adams and Hamilton, 1984). How- 
ever, stimulating macrophages with IFN-y pre- 
cludes the development of other functional stages. 
Thus, in general, activation markers are linked 
directly to the type of stimulus given, as well as to 
the type of responding macrophage. 
In the following sections we will discuss a 
panel of macrophage markers, classified as either 
immature or mature markers, subset markers or 
activation markers according to the criteria men- 
tioned above. Unfortunately, the discussion will 
show that very few of these markers, if any, are 
fully specific for a single category. Our experi- 
ence is that the same holds true for other 
macrophage markers not included in the present 
selection. Yet, using combinations of multiple 
markers from the different categories for the 
phenotyping of mouse macrophages permits a 
plausible description of their developmental stage 
in terms of relative (im)maturity, belonging to a 
particular subset or being (un)stimulated. 
2. Materials and methods 
2.1. Bone marrow cultures 
Macrophage development was followed in liq- 
uid bone marrow cultures timulated with M-CSF, 
as described before (Leenen et al., 1990a). Briefly, 
bone marrow was harvested from BALB/c mice 
(10-20 weeks of age), which had been kept under 
clean, routine conditions in accordance with insti- 
tutional guidelines for animal welfare. The cells 
obtained were cultured for various periods of 
time in DMEM, supplemented with 10% fetal 
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calf serum, 13% L-cell conditioned medium and 
antibiotics, and then phenotypically analyzed. 
2.2. Monoclonal antibodies 
The characteristics of and references for mon- 
oclonal antibodies (mAbs) described in this paper 
are summarized in Table 1. Hybridomas marked 
with "ER-" were established in our own depart- 
ment; M1/70, M3/38, M1/22.25, M5/114, 
YN1/1.7 and MA158.2 producing hybridomas 
were obtained from the American Type Culture 
Collection (Rockville, MD); mAbs and/or hy- 
bridomas designated BM8, F4/80, H35.89, 
MOMA-1, MOMA-2, Monts-4, MIV 38, SER-4, 
TM-2, TM-4, and TM-5 were kindly provided by 
the respective producers and/or BMA Biomedi- 
cals AG (Augst, Switzerland). For cellular stain- 
ing, either undiluted hybridoma supernatants or
optimally diluted purified antibody preparations 
were used. 
2.3. Immunofluorescence staining and flowcytomet- 
ric analysis 
Staining of cells was performed using routine 
procedures, essentially as described before 
(Leenen et al., 1990b). Cellular fluorescence as a 
measure of antibody binding was determined us- 
ing a FACScan (Becton Dickinson, Sunnyvale, 
CA) with logarithmic amplification of FITC fluo- 
rescence signals. Results are expressed either as 
percent positive cells compared to ceils stained 
with a control mAb, or as molecules equivalent to 
soluble FITC (MESF). The latter values were 
obtained by interpolation of cellular fluorescence 
values compared to a standard curve prepared 
using microspheres of known fluorescence inten- 
sity (Flow Cytometry Standards, Research Trian- 
gle Park, NC). 
3. Results and discussion 
Table 1 shows a selection of monoclonal anti- 
bodies directed against markers of different 
mouse macrophage developmental stages, i.e., 
universal immature and mature macrophage 
markers, subset markers, and macrophage activa- 
tion markers. As outlined above, the distinction 
between the different marker categories i  not 
always absolute. In particular, the discrimination 
between universal mature macrophage markers 
and subset markers is more or less arbitrary, 
since no markers exist, to our knowledge, that are 
expressed by all macrophages, and are relatively 
specific for these cells. In other words, all mature 
macrophage markers are in fact subset markers. 
Yet, a distinction between the two categories i
made on the basis of the widespread expression 
of universal mature markers by macrophages in 
vitro as well as in vivo, and the more restricted 
occurrence of subset markers. 
3.1. Immature macrophage markers 
The panel of immature macrophage markers, 
ER-MP12, -20, -54, and -58, has been generated 
against macrophage precursor hybrid cell lines 
and selected for the recognition of markers ex- 
pressed preferentially b  immature stages of mat- 
uration using in vitro models (Leenen et al., 
1990b). The decreasing expression of these mark- 
ers upon maturation of macrophages i  clearly 
illustrated by the decreasing percent of cells posi- 
tive for these markers during M-CSF-stimulated 
BM culture (Fig. 2). Additional studies by our- 
selves and others have confirmed and extended 
the initial characterization of these markers 
(Wijffels et al., 1993; McCormack et al., 1993; De 
Bruijn et al., manuscript submitted). 
Using these markers for identification of 
macrophage precursor cells, it should be realized 
that, in the macrophage lineage, ER-MP12, -20, 
-54 and -58 antigens are restricted to precursor 
stages, but these markers are also expressed by 
other cell types. In recent experiments, about 
40% of freshly isolated BM cells were repeatedly 
found positive for ER-MP12, in contrast with 
6-9% assessed earlier using less advanced tech- 
nology (cf. Leenen et al., 1990b; Slieker et al., 
1993a). This significant percent of BM ceils found 
positive for ER-MP12 already indicates that other 
hemopoietic ells are recognized as well. ER- 
MP12 also detects pluri- and multipotent stem 
cells and prothymocytes in BM as well as particu- 
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lar lymphoid cells in BM and peripheral lym- 
phoid organs (Slieker et al., 1993a,b; De Bruijn et 
al., manuscript submitted; Van der Loo et al., 
manuscript in preparation). Although the identity 
of the ER-MP12 antigen has not yet been estab- 
lished, it bears similarity to CD34 with regard to 
high level expression by early hemopoietic cells. 
The antigen recognized by ER-MP20 has been 
Table 1 
Monoclonal antibodies against markers of mouse macrophage development 
mAb Antigen Mol. mass Ag description Reference(s) 
(kDa) 
Immature macrophage markers 
ER-MP12 
ER-MP58 
ER-MP54 
ER-MP20 a Ly-6C 
Mature macrophage markers 
140 
90, 80-85, 
70-75 
14 
F4/80 a 160 
BM8 125 
M1/70 a Mac-la 170 
CDllb, 
Ly-40 
M3/38 a Mac-2, 32-35 
CBP35 
ER-BMDM1 a CD13? 160 
Macrophage subset markers 
ER-HR3 
ER-MP23 
ER-TR9 
M1/22.25 a Forssman 
Ag 
MOMA-1 
MOMA-2 
Monts-4 
SER-4 SER; sialo- 
adhesin 
Macrophage activation markers 
M5/114 a H-2Ia 
H35.89 a LFA-la, 
CDlla 
ICAM-1, 
MALA-2, 
CD54 
158.2 
MBR-2 
YN1/1.7 a 
MA158.2 
MIV 38 a 
TM-2 
TM-4 
TM-5 
76,67 (non- 
red.) 
69, 55 (red.) 
38 
80-100 
170-185 
25-34 
180 
95 
45 
Single chain (glyco)protein 
Glycoprotein, usually PI-linked 
Single-chain glycoprotein 
CR3a, fibrinogen R b, clot- 
ting factor X R, adhesion 
molecule 
Galactose-specific le tin; IgE- 
and laminin-binding protein 
Aminopeptidase N 
Two distinct single chain 
(glyco-)proteins; high M r 
form secreted 
Single chain (glyco-)protein 
Involved in M~b neutral 
polysaccharide uptake 
Glycosphingolipid hapten 
(Glyco-)protein 
Sialylated glycoconjugate R 
Heterodimer; Ag-peptide 
binding for presentation 
CD54 and ICAM-2 ligand 
CDl l /CD18 ligand 
Leenen et al., 1990b 
Leenen et al., 1990b 
Leenen et al., 1990b 
Leenen et al., 1990b 
Austyn and Gordon, 1981 
Malorny et al., 1986 
Springer et al., 
1979 
Ho and Springer, 
1982 
Leenen et al., 1992 
De Jong et al., 
1994a,b 
Leenen et al., 1991 
Van Vliet et al., 
1985 
Springer et al., 
1978 
Kraal and Janse, 1986 
Kraal et al., 1987 
Jutila et al., 1993 
Crocker and 
Gordon, 1989 
Bhattacharya et
al., 1981 
Pierres et al., 
1982 
Takei, 1985 
Koestler et al., 1988 
Martin et al., 1988 
Paulnock and Lambert, 1990 
D.M. Paulnock, personal comm. 
D.M. Paulnock, personal comm. 
a Also other mAbs with the same or similar reactivities have been reported. 
b R = receptor. 
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identified definitively as Ly-6C (McCormack et 
al., 1993) and is expressed by monocytes and 
granulocytes, as well as by a subpopulation of 
CD8 ÷ T cells. Quantitative analysis of ER-MP20 
antigen expression permits the identification of 
monocytes in BM as these cells show the highest 
antigen levels (De Bruijn et al., manuscript sub- 
mitted). BM macrophage colony-forming cells 
(M-CFC) are either ER-MP20 negative or show 
an intermediate l vel. The former are the most 
immature: they produce the largest colonies and 
pass through an ER-MP20 positive stage upon 
maturation i  vitro (De Bruijn et al., manuscript 
submitted). Mature macrophages, however, are 
ER-MP20 negative. Therefore, ER-MP20 is a 
typical marker of intermediate stages of BM-de- 
rived macrophage maturation. Surprisingly, in 
spleen all M-CFC are found in the ER-MP20 hi 
fraction, whereas no M-CFC are present in the 
corresponding fraction in BM (McCormack et al., 
1993). Although the origin of this distinction is 
not known, it is possible that environmental dif- 
ferences determine xpression of the ER-MP20 
antigen by macrophage progenitors: the antigen 
is significantly induced or up-regulated after in- 
terferon-y or interferon-o~//3 stimulation (unpub- 
lished and Jutila et al., 1988). The inducibility of 
ER-MP20 antigen expression is strikingly matura- 
tion-stage-dependent, as it can be induced in 
immature cells, but not in mature macrophages. 
The ER-MP54 antigen was selected as a sur- 
face marker of macrophage precursor cell lines, 
but appeared to be absent from the cell surface 
of normal BM cells (Leenen et al., 1990b). In- 
stead, BM cells express this marker only cytoplas- 
mically. Specific experimental conditions, such as 
corticosteroid treatment in vitro, may induce ER- 
MP54 surface expression on some non-trans- 
formed cells (unpublished). Immunohistological 
examination shows an ER-MP54 antigen distribu- 
tion that is restricted to presumed myeloid ceils: 
the majority of BM cells and some clusters in the 
splenic red pulp (unpublished). 
ER-MP58 demonstrates a similar, relatively 
specific, staining of myeloid cells in sections of 
BM and spleen (unpublished). Yet, this marker is 
present on the cell surface of the majority of 
normal BM cells, including virtually all M-CSF- 
responsive macrophage precursors (Leenen et al., 
1990b). Expression of ER-MP58 decreases signifi- 
cantly upon maturation of macrophages. How- 
ever, reduced levels can still be demonstrated on
BM-derived macrophages in vitro (Fig. 2) as well 
as on some macrophage cell lines with mature 
100 ~ 
80. 
8 
>~ 60 
O. 
40 ¸  
o_ 
20 ¸  
0 
0 1 2 3 4 5 6 7 8 9 10 
day of culture 
Fig. 2. Expression of immature macrophage markers in M-CSF-stimulated BM culture. Cells were harvested at different time 
points from liquid BM cultures and analyzed phenotypically using flow cytometry. The number of morphologically identifiable 
mononuclear phagocytes (i.e., monoblasts, (pro)monocytes and macrophages) in these cultures increases from less than 10% at day 
0 to 60-70% at day 4 and > 98% at day 7. Data represent the mean net percent of marker-positive c lls, compared to negative 
control values, as determined in at least two experiments; the standard eviations were less than 10%. 
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features. Thus, high level ER-MP58 expression is
characteristic of precursor cells, although the 
marker may be retained by some macrophages in 
more mature stages. 
Taken together, the markers detected by ER- 
MP12, -20, -54, and -58 are expressed selectively 
by immature cells of the macrophage lineage. 
However, other cell types may be positive for 
these markers as well, suggesting that expression 
of one or more of these antigens does not neces- 
sarily identify the cells under study as macrophage 
precursors. If, on the other hand, the macrophage 
identity of such cells has been established, then 
expression of ER-MP12, -20, -54 and/or -58 anti- 
gens is highly suggestive of their immature na- 
ture. 
3.2. Mature macrophage markers 
The panel of universal mature macrophage 
markers that we regularly use to demonstrate 
macrophage maturity includes F4/80, BM8, Mac- 
1, Mac-2 and ER-BMDM1. Fig. 3 shows the 
expression of these markers during M-CSF- 
stimulated BM culture. Despite the differences 
found in the percent of positive ceils in freshly 
isolated BM, all of these markers are expressed 
uniformly by the mature macrophages obtained 
8 
O_ 
E 
100 
80 
60 
40 
ER-BMDM1 
20- 
~ ~ ~ ;, ~ ~ -~ ~ 9 1'o 
day of culture 
160 
b ER-BMDM1 
,,~',,,~X 120 
.Q  
~ 40- 
i ° 
0 , f 
0 1 2 3 4 5 6 7 8 9 10 
day of culture 
Fig. 3. Expression of universal mature macrophage markers in M-CSF-stimulated BM culture, a: mean net percent of marker-posi- 
tive cells at different ime points during in vitro macrophage development (cf. legend Fig. 2); b: quantitative analysis of mAb 
binding to developing macrophages. Data represent the mean net antibody binding to the marker-positive c lls depicted in a. 
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from day 7 and beyond (Fig. 3a). Not only does 
the percentage of positive cells increase in these 
cultures as macrophages mature, the level of anti- 
body binding per cell increases even more dra- 
matically, indicating enhanced antigen expression 
by more mature cells (Fig. 3b). The differential 
staining of fresh BM for the different markers 
clearly reflects the presence (e.g., Mac-l) or ab- 
sence (e.g., ER-BMDM1) of these markers on 
other hemopoietic cell types, especially myeloid 
cells. 
The F4/80 antigen is perhaps the most univer- 
sal and widely used macrophage marker with 
relative specificity for this cell type. Expression of 
this marker commences early during macrophage 
development, but after the M-CFC stage (Hirsch 
et al., 1981). In vitro, most if not all mature 
macrophages xpress the F4/80 antigen, but in 
vivo some macrophage populations do not show 
detectable F4/80 antigen levels, especially those 
in lymphoid microenvironments (Witmer and 
Steinman, 1984). This lack of significant antigen 
expression may be due to high local concentra- 
tions of lymphocyte-derived cytokines, some of 
which have been shown to down-regulate F4/80 
antigen expression (Ezekowitz and Gordon, 1982). 
F4/80 is a selective, but not an exclusive marker 
for macrophages, ince freshly isolated eosino- 
phils as well as endothelial-like c lls in BM stro- 
mal cultures bind the F4/80 antibody (McGarry 
and Stewart, 1991; Penn et al., 1993). 
BM8 is a macrophage marker that bears signif- 
icant similarity to F4/80 (Malorny et al., 1986). 
Although the apparent molecular masses of these 
antigens are different, 125 kDa for BM8 vs. 160 
kDa for F4/80, the staining patterns obtained 
show a high degree of overlap. The original de- 
scription of BM8 showed expression of the anti- 
gen only by cells beyond the monocytic stage. In 
our hands, however, monocytes and myeloid pre- 
cursors also specifically bind small, but detectable 
amounts of the BM8 antibody as demonstrated by 
sensitive flow cytometry. 
The Mac-1 (CDllb/CD18) antigen was one of 
the first macrophage markers defined by mono- 
clonal antibody (Springer et al., 1979). Expression 
of Mac-1 is detected on cells beyond the M-CFC 
stage in bone marrow and spleen (Miller et al., 
1985; McCormack et al., 1993) and increases ig- 
nificantly with maturation ofmacrophages in vitro 
(Walker et al., 1985). Yet, Mac-1 is undetectable 
on many "tissue-fixed" macrophages, but is ex- 
pressed at different levels by virtually all "free" 
macrophage populations (Flotte et al., 1983; Nib- 
bering et al., 1987). In addition, granulocytes and 
NK cells express Mac-1 as well as activated and 
memory CD8 + cytotoxic T cells and some un- 
usual B-1 lymphocytes (Springer et al., 1979, 
Holmberg et al. 1981, Miyama-Inaba et al., 1988, 
McFarland et al., 1992). Using blocking studies, it 
was found that anti-Mac-1 mAb recognized the 
a-chain of type 3 complement receptor, a mem- 
ber of the integrin family (Belier et al., 1982). 
This receptor is involved in adhesive processes 
with different ligands. First of all, CR3 mediates 
uptake of opsonized microorganisms and parti- 
cles by binding of iC3b and C3d (reviewed by 
Brown, 1991). In addition, it was shown for 
macrophage - Listeria interactions, that CR3 not 
only functions as a receptor for internalization 
but also seems to trigger processes essential for 
killing of the bacterium (Drevets et al., 1993). 
Second, CR3 binds other molecules, such as fib- 
rinogen and clotting factor X, mostly through an 
Arg-Gly-Asp containing sequence in the ligand 
(Brown, 1991). Third, CR3 is critically involved in 
the recruitment of myelomonocytic cells in re- 
sponse to various inflammatory stimuli, probably 
by binding to ICAM-1 (CD54) molecules on the 
inflamed endothelium (reviewed by Rosen, 1990). 
Mac-2 was originally presented as a macro- 
phage subpopulation-specific marker (Ho and 
Springer, 1982). However, expression of this anti- 
gen closely correlates with macrophage matura- 
tion in all in vitro models (Fig. 3; l_eenen et al., 
1986, 1990a; Walker et al., 1985). It is induced in 
precursor cells at a relatively late stage, just pre- 
ceding the ability of cells to become adherent. 
Cloning and sequencing of the Mac-2 gene 
showed that it does not contain a classic signal 
peptide or transmembrane domain, indicating 
that it is mainly an intracellular protein (Cherayil 
et al., 1989). This is confirmed by the finding that 
the percentage of Mac-2 positive spleen cells 
increases from about 20% to more than 70% 
upon permeabilization of the cell membrane 
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(Leenen et al., 1987). The latter finding also 
implies that many cell types other than macro- 
phages also express the Mac-2 antigen. Mac-2 has 
been identified as a galactose-specific le tin. Cell 
surface xpression may thus be explained by bind- 
ing of secreted molecules to surface-bound glycan 
moieties, since binding is abolished by incubation 
of cells in the presence of competing sugar (Frigeri 
and Liu, 1992). 
The ER-BMDM1 Ag is, of the universal ma- 
ture markers described here, induced last on de- 
veloping macrophages (Fig. 3). BM cells as well 
as blood monocytes are essentially ER-BMDM1 
negative, and expression isobserved uniformly on 
all mature cells in the various models (Leenen et 
al., 1992). In vivo, however, only specific 
macrophage subpopulations are detected by this 
antibody, including about one third of the resi- 
dent peritoneal and alveolar macrophages. Cer- 
tain inflammatory macrophages, such as thiogly- 
collate-elicited cells, express high levels of this 
marker. Furthermore, populations belonging to 
the dendritic leukocyte lineage are mostly ER- 
BMDM1 positive. The biochemical characteris- 
tics of the antigen - a molecular mass of 160 kDa 
and demonstrated aminopeptidase N activity - 
suggest that this marker is the mouse homologue 
of human CD13 (Leenen et al., 1992). 
3.3. Macrophage subset markers 
As outlined before, the distinction between 
universal mature macrophage markers and subset 
markers is more or less arbitrary. Our criterion 
for classification is that subset markers are not 
universally expressed by all mature macrophages 
in the in vitro maturation models, in contrast o 
the universal mature markers. Also, subset mark- 
ers show a restricted distribution in vivo (see 
below). The subset markers that we use (ER-HR3, 
ER-MP23, ER-TR9, Forssman Ag, MOMA-1, 
MOMA-2, Monts-4, and SER-4) are typical of 
different macrophage subsets in tissue sections of 
various organs, and all, except Forssman antigen, 
show a high degree of specificity for mononuclear 
phagocytes. 
The macrophage subset marker ER-HR3 is 
expressed by a specific subpopulation of mouse 
macrophages, located especially in hemopoietic 
organs: bone marrow and splenic red pulp (De 
Jong et al., 1994a,b). The number of ER-HR3 
positive macrophages in the red pulp constitutes 
only a subset of all (F4/80 positive) red pulp 
macrophages, yet includes the so-called central 
macrophages of the erythropoietic islands. Induc- 
tion of extramedullary hemopoiesis in the liver by 
phenylhydrazine treatment of mice is accompa- 
nied by the appearance of ER-HR3 positive cen- 
tral macrophages. This observation supports the 
notion that the ER-HR3 positive macrophage 
subset is functionally involved with erythropoietic 
activity (De Jong et al., 1994b). Yet, other subsets 
which are not apparently involved with hemopoi- 
etic activity, such as those located in the lymph 
node paracortex and the ileal lamina propria, 
also express the ER-HR3 antigen (De Jong et al., 
1987). 
ER-MP23 is a marker particularly expressed 
by connective tissue macrophages, or histiocytes 
(Leenen et al., 1991). Interestingly, macrophages 
in many, but not all, connective tissues located 
near epithelia express high levels of this antigen: 
e.g. dermal macrophages and macrophages in the 
reticular connective tissue of the submandibular 
gland are strongly ER-MP23 positive, but those 
in the intestinal lamina propria are generally ER- 
MP23 negative. In addition to a location in con- 
nective tissue, ER-MP23 positive cells may also 
occur sparsely in lymphoid tissues. Furthermore, 
ER-MP23 positive non-lymphoid cells, being ei- 
ther macrophages or dendritic leukocytes, are 
among the first cells to infiltrate the pancreatic 
islets of the pre-diabetic NOD mouse (Jansen et 
al., 1994). In vitro studies of ER-MP23 expression 
among different macrophage populations and de- 
rived cell lines have indicated that macrophages 
are either strongly positive for this marker, or 
negative/dull. This ER-MP23 phenotype of in 
vitro maintained ceils is surprisingly stable; in our 
hands, an ER-MP23 -/dul~ cell line could not be 
converted by a variety of stimulants into an ER- 
MP23 hi cell line and vice versa (Leenen et al., 
1991). This led us to conclude that ER-MP23 
might be a subset marker characteristic of a dis- 
tinct lineage of macrophage development. 
ER-TR9 antigen expression is characteristic of
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splenic marginal zone macrophages and macro- 
phages located in the medullary and trabecular 
sinuses of lymph nodes (Van Vliet et al., 1985; 
Dijkstra et al., 1985). These highly phagocytic 
populations are unique in their ability to retain 
and ingest neutral polysaccharides, such as Ficoll 
and dextran. Interestingly, in vivo administration 
of the ER-TR9 antibody abolished endocytosis of
these polysaccharides, but did not influence the 
ability to ingest latex or carbon particles (Kraal et 
al., 1989). The ER-TR9 mAb probably does not 
recognize the binding site of the neutral polysac- 
charide receptor, since injection of polysaccha- 
rides prior to administration f the antibody did 
not diminish binding of the latter. 
The Forssman glycolipid antigen (Fo) is ex- 
pressed by a subset of stromal macrophages 
mainly associated with early hemo-lymphopoietic 
development: macrophages in bone marrow 
stroma, splenic red pulp, and thymic cortex 
(Sadahira et al., 1988, Miihlradt et al., 1989). 
Furthermore, medullary macrophages in inguinal 
and axial lymph nodes, but not in mesenteric 
lymph nodes, express Fo. This marker is less 
specific for mononuclear phagocytes than the 
other subset markers from the present selection; 
in adult tissues also reticular ceils in various 
organs and thymic epithelial cells are Fo ÷, 
whereas developing mesenchymal cells express 
Fo transiently. Fo expression is inducible by IL-4 
or IL-6 in a small percent of macrophages in a 
specific stage of development (Kleist et al., 1990). 
The antigen recognized by MOMA-1 is ex- 
pressed by a macrophage subset ypified by the 
metallophilic macrophages at the white pulp side 
of the marginal sinus in the spleen, and capsular 
and medullary sinus macrophages in peripheral 
lymph nodes (Kraal and Janse, 1986). These pop- 
ulations are characterized by a high level of non- 
specific esterase activity, which, linked to their 
strategic location, is suggestive of a degrading 
and detoxifying function (Kraal, 1992). Injection 
of the MOMA-1 mAb into neonatal mice led to a 
significant reduction of the presence of MOMA-1 
positive cells, and concomitantly, to impaired hu- 
moral immune responses against hymus-depend- 
ent (TD) and thymus-independent type 2 (TI-2) 
antigens (Kraal et al., 1988). This suggests a role 
for the marginal metallophilic macrophages in
the presentation of these antigens, although in 
the neonate a subpopulation of cells located in 
the red pulp also shows MOMA-1 expression and 
may thus be involved in the immune response 
against TD and TI-2 antigens. 
The MOMA-2 mAb is especially useful for the 
identification of macrophages in lymphoid tissues 
(Kraal et al., 1987). Most, if not all, macrophages 
in lymphoid microenvironments show high level 
expression of this marker. The antigen is located 
primarily in the cytoplasm, but it can also be 
demonstrated on the cell surface. The expression 
of the MOMA-2 antigen shows a high degree of 
similarity with the expression of acid phos- 
phatase, including the localization of both mark- 
ers to a cytoplasmic region of dendritic leuko- 
cytes. MOMA-2 is expressed early during the 
development of mononuclear phagocytes, ince a 
significant fraction of BM cells as well as all 
blood monocytes are positive. 
Immunohistological examination of the expres- 
sion of the Monts-4 antigen suggests that this 
marker is expressed by both MOMA-1 and 
MOMA-2 positive subsets (Jutila et al., 1993). 
Yet, many macrophage populations do not ex- 
press Monts-4, including most splenic red pulp 
macrophages. Expression of the antigen de- 
creases quickly upon culture of isolated Monts-4 + 
macrophages, suggesting the necessity of continu- 
ous stimulation for Monts-4 expression. In agree- 
ment with this, we have never observed signifi- 
cant Monts-4 antigen expression by in vitro main- 
tained macrophages, including transformed as 
well as growth factor-dependent cell lines and 
BM-derived macrophages. 
The macrophage subset marker SER, identi- 
fied by mAb SER-4, has been characterized most 
extensively in relation to the function of the anti- 
gen and the antigen-expressing macrophages in
hemopoiesis (Crocker and Gordon, 1989). Ini- 
tially identified as a receptor for sheep erythro- 
cytes, SER is now also known as sialoadhesin, a 
receptor for sialylated glycoconjugates occurring 
on developing hemopoietic cells. Antibodies 
against SER are able to block interactions be- 
tween sialylated compounds and SER. Interest- 
ingly, ligand binding to SER does not induce 
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phagocytosis, suggesting that SER's primary func- 
tion is to maintain physical contact between cells 
and/or mediate signal transduction. The recep- 
tor is expressed by stromal macrophages at 
hemopoietic sites, such as resident BM macro- 
phages and a subset of splenic red pulp macro- 
phages, but also by macrophages in lymphoid 
microenvironments, such as splenic marginal met- 
allophils and lymph node subcapsular and 
medullary macrophages. Here, SER is thought to 
be involved in the interaction between stromal 
macrophages and activated T cells and plas- 
mablasts (Damoiseaux et al., 1991). 
3.4. Macrophage activation markers 
A fourth category of macrophage markers 
comprises antigens induced by activating agents. 
Induced expression of such activation markers is 
accompanied by, and in the ideal situation indica- 
tive of, specific functional acquisitions. Generic 
activation markers, however, do not exist, since 
the phenotypic and functional response of a 
macrophage depends greatly on the nature of 
both the stimulus ~nd the responding cell. Yet, 
IFN-y is a major stimulator of multiple 
macrophage functions, and was therefore chosen 
as a "model activating agent" to identify 
macrophage activation markers. As the following 
discussion will show, many of the present activa- 
tion markers are also induced by other agents. 
Expression of MHC class II antigens, in the 
mouse H-2Ia, is induced in most macrophages by
IFN-y, as well as by a number of other stimuli 
including IL-4, GM-CSF and IL-3 (Steeg et al., 
1982; Crawford et al, 1987; Willman et al., 1989; 
Frendl and Belier, 1990). On the other hand, 
IFN-a//3 and M-CSF have been shown to coun- 
teract the IFN-y- or GM-CSF-mediated induc- 
tion of Ia expression (Ling et al., 1985; Willman 
et al., 1989). Colony-forming macrophage precur- 
sors do not express Ia antigens (Miller et al., 
1985), but expression is induced during in vitro 
development in about 15-30% of the ceils (un- 
published observation; Falk et al., 1988). This 
apparent heterogeneity is not clonally deter- 
mined, however (Yen et al., 1987). Expression of 
Ia molecules i  a prerequisite for macrophages to 
present antigen to CD4 + T helper cells, but not a 
'proof' of their ability to do so; productive stimu- 
lation of Th cells requires appropriate co-stimula- 
tory signals in addition to Ia-bound antigenic 
peptides (Liu and Linsley, 1992). 
LFA-1 (CDlla/CD18) belongs to the integrin 
family and shares its /3-chain type with Mac-1 
and p150/95 (CDllb and CDllc, respectively). 
Expression of LFA-1 is already found on imma- 
ture cells, since part of BM M-CFC is LFA-1 + 
(Miller et al., 1985). Yet, among more mature 
ceils, LFA-1 can be considered a marker of 
primed and activated stages and its expression 
can be induced by several stimulants including 
IFN-y, LPS, IL-4 and IL-3 (Strassmann et al., 
1985; Frendl and Belier, 1990). Various 
macrophage populations, however, are refractory 
with respect o the induction of LFA-1 (Strass- 
mann et al., 1985). As an integrin, LFA-1 is 
critically involved in many cellular interactions 
and is a ligand for ICAM-1, ICAM-2 and possibly 
others. However, to be functional, the LFA-1 
molecule needs to be activated to reach a high-af- 
finity state (Figdor et al., 1990). Therefore, ex- 
pression of LFA-1 is a sign of potential, but not 
necessarily actual, involvement in LFA-I-ICAM 
interactions. 
The major ligand of LFA-1, ICAM-1 (CD54), 
may also be considered a macrophage activation 
marker. Expression of this member of the im- 
munoglobulin superfamily is induced by a variety 
of inflammatory c tokines, including IFN-y, IL-1 
and TNF-a (Dustin and Springer, 1988). ICAM-1 
shows a widespread cellular and tissue distribu- 
tion, including vascular endothelium, lympho- 
cytes, monocytes, macrophages and dendritic 
leukocytes (Prieto et al., 1989). This suggests that 
the ICAM-1-LFA-1 interaction is probably regu- 
lated at the level of activation of the LFA-1 
molecule. 
The antigen 158.2 is another IFN-y-inducible 
marker for macrophages in both mature and im- 
mature stages of development (Koestler et al., 
1984; 1985). In addition, expression of 158.2 can 
be induced by LPS, but not by IFN-a//3, mu- 
ramyl dipeptide or bestatin. The initial character- 
ization of this marker suggested a link between 
enhanced 158.2 expression and tumoricidal 
16 P.J.M. Leenen et al. /Journal of lmmunological Methods 174 (1994) 5-19 
and/or bactericidal activity of macrophages. In
our hands, however, IFN-y also induces high 
level expression of this marker in macrophage 
precursor cells without inducing concomitant cy- 
totoxic activities (unpublished results). 158.2 is 
weakly expressed by resident macrophages, but 
can be demonstrated at significant levels on exu- 
date macrophages as well as exudate granulo- 
cytes. 
MBR-2 is one of a cluster of antigenic deter- 
minants on the same or closely associated 
molecules (Martin et al., 1988). Initially, this 
marker was defined on a subpopulation of B 
cells, but its presence on macrophages and ery- 
throcytes was also recognized (Kung et al., 1982). 
In contrast o the activation markers described 
above, MBR-2 is induced by IFN-y only on 
macrophages in the more mature stages of devel- 
opment (unpublished). Expression of MBR-2 is 
not fully dependent on induction by IFN-3,, how- 
ever, since macrophages maturing in vitro show 
increasing expression of MBR-2 in the absence of 
IFN-y stimulation (Falkenberg et al., 1989). Resi- 
dent peritoneal macrophages also express ignifi- 
cant levels of MBR-2. The immunohistochemical 
profile of anti-MBR mAbs is characterized par- 
ticularly by reactivity with capillary endothelia. 
The TM-2, TM-4, and TM-5 antibodies were 
raised against IFN-y stimulated RAW264 
macrophage tumor cells in order to obtain mark- 
ers for intermediate stages in the tumoricidal 
activation pathway (Paulnock and Lambert, 1990; 
D.M. Paulnock, personal communication). As 
such, these antigens are expressed by stimulated 
RAW264 cells, but not by IFN-y-stimulated 
WEHI-3 cells that cannot be induced to express 
tumoricidal activity. Likewise, resident peritoneal 
macrophages, which cannot be induced to kill 
tumor cells, fail to express these antigens after 
stimulation. Induction of TM-2, -4 and -5 expres- 
sion by responsive cells is relatively specific for 
IFN-y exposure, since I FN-a / f l ,  TNF-a, LPS, 
1L-4 and GM-CSF are ineffective in this respect. 
Analysis of TM-antigen profiles of different exu- 
date macrophage populations revealed a more 
complex pattern, suggesting that TM-4 and -5 
antigens are associated with an inflammatory 
phenotype, while induction of TM-2 occurs dur- 
ing the later stages of activation to tumoricidal 
activity. 
4. Concluding remarks 
The available mAbs against mouse mononu- 
clear phagocyte markers, of which the current 
panel is only a selection, permit us to identify 
different stages in the development of these cells. 
Using multiple markers from each category, we 
feel confident in determining from the cellular 
phenotype whether macrophages are immature, 
mature, belong to a specific subset, or are more 
or less stimulated. This classification is still rather 
crude, and definitely needs further refinement. 
This, however, can only be achieved when more 
insight is obtained into the developmental rela- 
tionships between the various members of the 
mononuclear phagocyte system and the pheno- 
typic hallmarks that identify the different stages. 
Considering the "rudimentary" classification, 
caution should be exercised in drawing conclu- 
sions from results obtained with single markers, 
since many experimental conditions unexpectedly 
induce or suppress the expression of particular 
antigens. Such an "aberrant" phenotype is likely 
to have functional significance. This, however, 
remains elusive until the function of the irregu- 
larly up- or down-modulated antigen has been 
clarified. Unfortunately, many markers described 
in this overview still lack a functional designation, 
thus leaving us with "good guesses" in relating 
the cellular phenotype to a specific cellular func- 
tion. A major effort of the forthcoming years, 
therefore, will be to transform these "good 
guesses" into "solid evidence" by elucidating the 
functions of the various macrophage markers and 
translating these in terms of cellular capabilities. 
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